Nanjing RegeneCore Biotech Cπ§o.,Ltd is established in the Bi∑≈>✘omedical Valley of National Nanjing Jiangbei New ∑​✔>Area, with a research and of $© fice base of nearly 4000 squarα‌e meters. It is one of✘÷≤ the first research and development institutio↑•‍↓ns in the field of nanobodies in C←♣‌γhina. The company's international scientific•® consulting expert team has rich≤σ experience in the researc∏÷>h and development of cell therapy produc×'→<ts and clinical applications, providin₹®♠g strong guarantees for the precise positioning∏₩ and success rate of research and devel→£π≠opment products. The company has mat≤ ↓​ure and leading nanobody s‌≤¥creening technology, and ←♦conducts in-depth developm♥☆↕•ent in multiple application field •s based on this technology.